Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis.

[1]  K. Nicolaides,et al.  Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  L. Gortner,et al.  Differences in Rates and Short-term Outcome of Live Births Before 32 Weeks of Gestation in Europe in 2003: Results From the MOSAIC Cohort , 2008, Pediatrics.

[3]  K. Leveno,et al.  Neonatal Mortality and Morbidity Rates in Late Preterm Births Compared With Births at Term , 2008, Obstetrics and gynecology.

[4]  J. Martin,et al.  Births: final data for 2005. , 2007, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[5]  Roberto Romero,et al.  Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[6]  J. Weeks,et al.  Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double‐blind, placebo‐controlled trial , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  J. Weeks,et al.  Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double‐blind, placebo‐controlled trial , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  Elizabeth A Thom,et al.  A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. , 2007, The New England journal of medicine.

[9]  K. Nicolaides,et al.  Progesterone and the risk of preterm birth among women with a short cervix. , 2007, The New England journal of medicine.

[10]  J. Wit,et al.  Changes in Neonatology: Comparison of Two Cohorts of Very Preterm Infants (Gestational Age <32 Weeks): The Project on Preterm and Small for Gestational Age Infants 1983 and The Leiden Follow-Up Project on Prematurity 1996-1997 , 2005, Pediatrics.

[11]  W. Callaghan,et al.  Estimated Effect of 17 Alpha-Hydroxyprogesterone Caproate on Preterm Birth in the United States , 2005, Obstetrics and gynecology.

[12]  Paula R Williamson,et al.  Cervical cerclage for prevention of preterm delivery in woman with short cervix:randomised controlled trial , 2004, The Lancet.

[13]  Steve N Caritis,et al.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. , 2003, The New England journal of medicine.

[14]  C. Crowther,et al.  Birth outcomes: utility values that postnatal women, midwives and medical staff express , 2003, BJOG : an international journal of obstetrics and gynaecology.

[15]  J. Hibbard,et al.  Cervical Length at 16–22 Weeks' Gestation and Risk for Preterm Delivery , 2000, Obstetrics and gynecology.

[16]  H. Wolfe,et al.  Patients with an ultrasonographic cervical length < or =15 mm have nearly a 50% risk of early spontaneous preterm delivery. , 2000, American journal of obstetrics and gynecology.

[17]  M. Dombrowski,et al.  The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 2000, American journal of obstetrics and gynecology.

[18]  Ichael,et al.  Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 2000, The New England journal of medicine.

[19]  M. Dombrowski,et al.  The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1999, American journal of obstetrics and gynecology.

[20]  S. Cessie,et al.  Differences in the valuation of birth outcomes among pregnant women, mothers, and obstetricians. , 1999, Birth.

[21]  K. Nicolaides,et al.  Cervical length at 23 weeks of gestation: the value of Shirodkar suture for the short cervix , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[22]  G. Thurnau,et al.  The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1998, American journal of obstetrics and gynecology.

[23]  S F Bottoms,et al.  The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. , 1998, American journal of public health.

[24]  G. Thurnau,et al.  The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1996, American journal of obstetrics and gynecology.

[25]  S F Bottoms,et al.  The preterm prediction study: a clinical risk assessment system. , 1996, American journal of obstetrics and gynecology.

[26]  B. Mercer,et al.  The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth , 1996, Obstetrics and gynecology.

[27]  E. Thom,et al.  The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. , 1996, The New England journal of medicine.

[28]  J. Hauth,et al.  Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis , 1995, The New England journal of medicine.

[29]  S. Thung,et al.  Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. , 1991, The New England journal of medicine.

[30]  M. Armstrong,et al.  Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. , 1991, American journal of obstetrics and gynecology.

[31]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[32]  J. Iams,et al.  A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. , 1987, American journal of obstetrics and gynecology.

[33]  Paula R. Williamson,et al.  Cervical cerclage for prevention of preterm delivery in women with a short cervix: A randomized, controlled trial , 2005 .

[34]  P. Romano,et al.  Estimates of the economic costs of birth defects. , 1994, Inquiry : a journal of medical care organization, provision and financing.